136 related articles for article (PubMed ID: 18184075)
1. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.
Seyler C; Messou E; Gabillard D; Inwoley A; Alioum A; Anglaret X
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1338-47. PubMed ID: 18184075
[TBL] [Abstract][Full Text] [Related]
2. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
[TBL] [Abstract][Full Text] [Related]
4. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
[TBL] [Abstract][Full Text] [Related]
5. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.
Lawn SD; Myer L; Bekker LG; Wood R
BMC Infect Dis; 2006 Mar; 6():59. PubMed ID: 16551345
[TBL] [Abstract][Full Text] [Related]
6. Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008.
Abo Y; Minga A; Menan H; Danel C; Ouassa T; Dohoun L; Bomisso G; Tanoh A; Messou E; Eholié S; Lewden C; Anglaret X
BMC Infect Dis; 2013 Dec; 13():607. PubMed ID: 24373303
[TBL] [Abstract][Full Text] [Related]
7. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholié S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X;
Lancet; 2006 Jun; 367(9527):1981-9. PubMed ID: 16782488
[TBL] [Abstract][Full Text] [Related]
8. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan.
Duvignac J; Anglaret X; Kpozehouen A; Inwoley A; Seyler C; Toure S; Gourvellec G; Messou E; Gabillard D; Thiébaut R
HIV Clin Trials; 2008; 9(1):26-35. PubMed ID: 18215979
[TBL] [Abstract][Full Text] [Related]
10. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
11. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
[TBL] [Abstract][Full Text] [Related]
12. Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.
Galy A; Ciaffi L; Le Moing V; Eymard-Duvernay S; Abessolo H; Toby R; Ayangma L; Le Gac S; Mpoudi-Etame M; Koulla-Shiro S; Delaporte E; Cournil A;
Antivir Ther; 2016; 21(6):547-552. PubMed ID: 26882335
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
14. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
[TBL] [Abstract][Full Text] [Related]
15. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
17. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
[TBL] [Abstract][Full Text] [Related]
18. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
19. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
